North America Digestive Enzyme Supplements Market Size, Share & Industry Trends Analysis Report By Application (Additional supplements, Medical & Infant Nutrition and Sports Nutrition), By Origin (Animal, Plant, Microbial), By Country and Growth Forecast, 2022 - 2028

The North America Digestive Enzyme Supplements Market is expected to witness market growth of 6.5% CAGR during the forecast period (2022-2028).

Several enzymes from the stem or pulp of pineapples are used to make bromelain. Because it aids in protein digestion, bromelain is regarded to be beneficial in easing stomach symptoms as well as inflammation brought on by injury or infection. Research on bromelain's efficacy in reducing arthritis pain has yielded some contradictory results. There is a lot of anecdotal support for the use of bromelain as a digestive aid, but little formal study support.

Bromelain should normally be taken with meals multiple times a day and the dosage recommendations may vary. It is essential to receive a doctor's approval before taking bromelain because it may interfere with the way prescription medications work. Supplementing with digestive enzymes seems to be a relatively risk-free way to treat digestive problems. It may be less certain, though, whether the consumer is expected to notice a significant improvement in the symptoms.

IBS, or Irritable Bowel Syndrome, is a very common disease in regional countries. According to the Canadian Psychology Association, Canada has a wide prevalence of IBS. Irritable bowel syndrome (IBS) symptoms include lower abdominal pain or discomfort as well as frequent, severe diarrhea or constipation. Bloating is an additional typical symptom. IBS is a gastrointestinal (GI) tract illness that affects the lower gut. It is believed to be an issue with the way the gut functions. It is believed to be the result of issues with gut-brain communication.

The US market dominated the North America Digestive Enzyme Supplements Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $382.6 Million by 2028.The Canada market is poised to grow at a CAGR of 8.9% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 7.9% during (2022 - 2028).

Based on Application, the market is segmented into Additional supplements, Medical & Infant Nutrition and Sports Nutrition. Based on Origin, the market is segmented into Animal, Plant, Microbial and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Additional supplements
• Medical & Infant Nutrition
• Sports Nutrition

By Origin

• Animal
• Plant
• Microbial
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• ProThera, Inc.
• Enzymes, Inc.
• AST Enzymes
• Vemo 99 Ltd.
• Zeus Biotech Pvt. Ltd.
• Metagenics, Inc.
• Xymogen
• HVL, LLC
• Ortho Molecular Products, Inc.
• Enzymedica, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free